
April 30 (Reuters) - Glanbia PLC GL9.I:
GLANBIA - Q1 GROUP PERFORMANCE IN LINE WITH EXPECTATIONS, GROUP REVENUE GROWTH OF 7.2% (2.7% OF WHICH RELATED TO ACQUISITIONS)
GLANBIA - REITERATING FULL YEAR GUIDANCE OF ADJUSTED EPS OF 124 $CENT TO 130 $CENT, IMPACTS OF CURRENTLY KNOWN DIRECT TARIFFS LARGELY MITIGATED
GLANBIA - PERFORMANCE NUTRITION (PN) REVENUE -6.6% (-4.8% EXCLUDING SLIMFAST) WITH OPTIMUM NUTRITION REVENUE -3.1%, PRIMARILY DUE TO ANTICIPATED LOWER REVENUES IN US CLUB AND SPECIALTY CHANNELS
GLANBIA - HEALTH & NUTRITION (H&N) REVENUE +24.9% (OF WHICH 19.3% RELATED TO THE ACQUISITION OF FLAVOR PRODUCERS), DRIVEN BY STRONG VOLUME GROWTH
GLANBIA - DAIRY NUTRITION (“DN”) REVENUE GROWTH OF 18.9%, PRIMARILY AS A RESULT OF GOOD DEMAND FOR PROTEIN SOLUTIONS AND STRONG DAIRY MARKET PRICING
GLANBIA - €50 MILLION SHARE BUYBACK ON-GOING WITH €42.7 MILLION REPURCHASED TO DATE, EXPECTS TO RECOMMENCE DURING Q2
GLANBIA - GOOD PROGRESS ON MITIGATING SHORT-TERM INPUT COST INFLATION IN PN WITH WHEY PRICES ELEVATED BUT OFF THEIR PEAK, REITERATING PN MARGIN EXPECTATIONS DUE TO GOOD COST VISIBILITY TO YEAR-END
GLANBIA - CONTINUED PROGRESS TRANSFORMATION PROGRAMME WITH DN ON TRACK TO BE STANDALONE BUSINESS BY JULY 1, EXIT OF NON-CORE BUSINESSES UNDERWAY